Research Article
A Comparison between Gadofosveset Trisodium and Gadobenate Dimeglumine for Steady State MRA of the Thoracic Vasculature
Table 1
Tabular description of patient demographics and dosing for each contrast agent. No significant difference in patient age or weight between groups. Statistically significant dose difference () is calculated based on dose relative to “standard dose” of 0.03 mmol/kg gadofosveset trisodium and 0.1 mmol/kg gadobenate dimeglumine.
|